Tested Applications
| Positive WB detected in | T-47D cells, HEK-293T cells, HeLa cells |
| Positive IP detected in | HEK-293T cells |
| Positive IHC detected in | human prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26000-1-AP targets KIF14 in WB, IHC, IF, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag23219 Product name: Recombinant human KIF14 protein Source: e coli.-derived, PET30a Tag: 6*His Domain: 1299-1648 aa of BC113742 Sequence: SDRAIQSLTIQTACAFEQLVVLMKHWLSDLLPCTNIARLEDELRQEVKKLGGYLQLFLQGCCLDISSMIKEAQKNAIQIVQQAVKYVGQLAVLKGSKLHFLENGNNKAASVQEEFMDAVCDGVGLGMKILLDSGLEKAKELQHELFRQCTKNEVTKEMKTNAMGLIRSLENIFAESKIKSFRRQVQEENFEYQDFKRMVNRAPEFLKLKHCLEKAIEIIISALKGCHSDINLLQTCVESIRNLASDFYSDFSVPSTSVGSYESRVTHIVHQELESLAKSLLFCFESEESPDLLKPWETYNQNTKEEHQQSKSSGIDGSKNKGVPKRVYELHGSSAAVSSEECTPSRIQWV Predict reactive species |
| Full Name | kinesin family member 14 |
| GenBank Accession Number | BC113742 |
| Gene Symbol | KIF14 |
| Gene ID (NCBI) | 9928 |
| RRID | AB_2880327 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q15058 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for KIF14 antibody 26000-1-AP | Download protocol |
| IP protocol for KIF14 antibody 26000-1-AP | Download protocol |
| WB protocol for KIF14 antibody 26000-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-KIF14 antibody (Cat# 26000-1-AP) has 6 total citations, published in Cell Death Discovery, Pharmaceuticals, Journal of Cellular and Molecular Medicine, Carcinogenesis, Journal of Thoracic Disease, and BMC Urology. The research fields are all within oncology, spanning gastric cancer, glioma, anaplastic thyroid carcinoma, gallbladder cancer, lung adenocarcinoma, and clear cell renal cell carcinoma. Applications used include IHC, WB, and IF in human samples.
| Species | Application | Title |
|---|---|---|
Cell Death Discov Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14/AKT pathway | ||
Pharmaceuticals (Basel) Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis | ||
J Cell Mol Med BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability | ||
Carcinogenesis NUF2 and NEK2 promote malignant progression of gallbladder cancer by remodeling the extracellular matrix | ||
J Thorac Dis Exploring diverse programmed cell-death patterns to develop a novel gene signature for predicting the prognosis of lung adenocarcinoma patients | ||
BMC Urol KIF14 plays a role in the regulation of the cell cycle and has implications for prognosis in clear cell renal cell carcinoma |











